secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001213900-26-015239
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals regains Nasdaq compliance on minimum bid price; delisting hearing cancelled
--------------------------------------------------------------------------------

- Received Nasdaq notice on Feb 11 confirming compliance with minimum bid price rule 5550(a)(2).
- Prior delisting notice from Jan 20, 2026 was appealed and stayed pending hearing.
- Hearing scheduled for Feb 19, 2026 has been cancelled; matter closed.
- Company's common stock and warrants continue trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026015239/0001213900-26-015239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026015239/ea0276747-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-015239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer